Kirby Hitt, MD
Orthopaedic Surgery · Temple, TXNPI 1083674642
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $8,077,920 of the $9,056,625 with a category attached, or 89.2%. Stryker accounts for 100.0% of it on its own, with 5 other manufacturers making up the rest. Among orthopaedic surgery clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,226 payments — averaging $7387.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$9.1M
- Next Science LLC$130
- Orthosensor Inc.$82
- Abiomed$51
- Onkos Surgical, Inc.$35
- Smith+Nephew$22
Across 5 payments — averaging $368.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Stryker$2K
What the payments were for
- Royalty or licence$8,077,92089%
- Consulting fees$727,1258%
- Travel & lodging$231,9293%
- Food & beverage$19,6510%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 1,220 | $9,056,305 |
| Next Science LLC | 1 | $130 |
| Orthosensor Inc. | 1 | $82 |
| Abiomed | 2 | $51 |
| Onkos Surgical, Inc. | 1 | $35 |
| Smith+Nephew | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,056,625 in reported general payments places this provider in the 95th percentile of 1,337 orthopaedic surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 541 | $3,163 |
| Mupirocin | 145 | $1,048 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 76 | $627 |
| Celecoxib | 22 | $522 |
| Tramadol Hcl | 196 | $402 |
| Meloxicam | 79 | $290 |
| Ondansetron Hcl | 23 | $85 |
| Lactulose | 16 | $61 |
| Amoxicillin | 11 | $12 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Temple
- Stephen BurkhartSan Antonio$185.3M
- Robert GrahamAustin$6.3M
- Richard JonesDallas$6.3M
- Stefan KreuzerHouston$6.2M
- Michael WirthSan Antonio$4.5M
- Stephen IncavoHouston$4.3M
- Thomas EdwardsHouston$4.1M
- James BrodskyDallas$2.5M
- Robert SchmidtFort Worth$2M
- Sumant KrishnanDallas$1.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.